Trim MDT toward 2.5% portfolio cap; execute at market around 88.64 or limit order at 89-90; scale trim over 2-3 sessions; stop remaining position below 87; use proceeds for dry powder or reallocation to higher conviction names; reject 93 stop as overly generous; maintain defensive but not panicked posture.

• Support trimming MDT but not at 91.50 entry—already missed that level; trim at market around 88.64 or limit between 89-90
• Reduce toward 2.5% portfolio cap but scale over 2-3 sessions to avoid signaling and capture reflexive bounce
• Stop on remaining position should be below 87, not 93—93 stop is a coiled spring that virtually guarantees stop-out on short covering bounce
• FCF weakness is a warning to reduce exposure but not catastrophic—historical FCF oscillates between 460 million and 2.3 billion across quarters, suggesting normal intra-year volatility
• Forward P/E of 13.84x is not a valuation floor but a sequence of downside earnings risk that market may be slow to price
• Dividend Aristocrat with 35+ years of increases and 1.46x FCF coverage ratio are important but relative attractiveness narrows when 30-year yields are at multi-decade highs and 97% odds of no rate cuts in 2026
• Balance sheet still solid with 2.07 current ratio and net debt to EBITDA of 2.5x
• ISRG da Vinci 5 trade-in acceleration is real but not new information; using BSX 55% drawdown to argue universal compression is selection bias
• MDT's relative stability is part of investment thesis, not a reason to discount it
• HOLD with deteriorating technical structure, sequential earnings softness, and macro headwind is a slow bleed, not capital preservation

→ vs aggressive: The trader's 91.50 trim entry is already below current price of 88.64—executing at that level requires accepting slippage or chasing, which is forcing a trade. The 93 stop at current price of 88.64 is 1.25 ATRs above in a stock that broke its 50-day SMA, lost its 10 EMA, and sits on the 200 day SMA with expanding negative MACD—this stop will get hit on any short covering bounce.

→ vs neutral: HOLD recommendation is dangerous slow bleed given macro environment that no longer exists—97% odds of no rate cuts in 2026 and 30-year yields at multi-decade highs narrow the 3.25% dividend's relative attractiveness. Defensive flows rotate out when bond yields rise and are not unconditional. 13.84x Forward P/E is not a valuation floor given rising 10% recession probability and elevated EPS revision risk.

TRIM: Half at market ($88–$88.50 fill zone), half via limit order ($89–$89.50); residual stop at $87.50 closing basis; hard exit below $87.50; reassess post Q2 FY27 earnings

• $88.64 current price, $91.50 entry no longer available as it is now overhead resistance
• ATR is $2.07; intraday ranges include $1.42 swings; $87.50 stop provides buffer against noise without being too wide
• Forward P/E of 13.84x on $6.41 forward EPS is not a trap in this trim framework; the risk applies if holding full position without adjusting
• Q1 FY27 FCF of $1.29B is mid-range within the $0.46B–$2.30B historical quarterly range, not structural deterioration
• Dividend coverage at 1.46x and net debt to EBITDA at 2.5x remain intact; seasonal working capital drag of $665M is recurring pattern
• 50 SMA (~$89–$89.50) often retested as a bull trap after breakdown before downtrend continues; limit order placement captures this if it materializes
• Dividend Aristocrat floor historically supports $80–$84 zone, but elevated yields compress the relative yield advantage vs. Treasuries
• MACD histogram expanding negative, VWMA sloping lower; sellers controlling volume for two weeks; phasing in momentum tape risks selling into both bounce and breakdown
• If stock closes above $89.46 with rising volume for two consecutive sessions, pause on further trimming as technical repair signal
• Expected value framework favors trim with these parameters regardless of whether next major move is up or down

→ vs aggressive: $91.50 entry does not exist at current price; chasing a position reduction is forced execution from a position of weakness, not bold execution

→ vs aggressive: $93 stop is 1.25x ATRs above current price in a tape that gapped down five sessions in a row with both the 50 SMA and 10 EMA flipped to resistance; any short covering or mean reversion fills the stop at $93, locking in worse exit prices than the trim entry

→ vs aggressive: Forward P/E trap argument proves too much—it argues for the trim (agreed upon) but not for the urgency or specific price points desired

→ vs aggressive: '38% FCF collapse' is selective framing; Q1 FY27 at $1.29B is mid-range within the 5x historical quarterly range, not catastrophic structural deterioration

→ vs conservative: Defensive characteristics (Dividend Aristocrat, 0.57 beta) don't function the same as two years ago when 30-year yields were at 3%; with 30-year at multi-decade highs and 97% odds of no 2026 rate cuts, the relative yield advantage has compressed and defensive flows have redirected toward fixed income

→ vs conservative: HOLD implicitly assumes defensive flows will catch a falling knife; that is hope dressed as defensive posture, not risk management

→ vs conservative: Phasing over two to three sessions in a momentum tape (expanding MACD negative, VWAM sloping lower, sellers controlling volume) risks capturing worst of both: selling into dead cat bounce AND into breakdown

→ vs conservative: Stop below $87 in a stock with $2.07 ATR and $1.42 intraday swings is tight enough to get whipsawed by routine volatility; would get stopped out while stock closes at $87.20 and continues lower